Evaluation of drug interventions for the treatment of sleep disorders in children with autism spectrum disorders: a systematic review

• Main Authors: Ensiyeh Jenabi (Author), Sara Ataei (Author), Saeid Bashirian (Author)
• Format: Book
• Published: Korean Pediatric Society, 2019-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 1738-1061; 2092-7258; 10.3345/kjp.2019.00668
• Keywords: drug; sleep disorders; autism spectrum disorders; meta-analysis; Pediatrics; RJ1-570
• Source: Korean Journal of Pediatrics, Vol 62, Iss 11, Pp 405-409 (2019)

A structured review study of drug interventions on sleep disorders in patients with autism spectrum disorders (ASD) has not been published to date. This systematic review aimed to investigate drug interventions for the treatment of sleep disorders in children with ASD. The Web of Science, PubMed, and Scopus databases were searched until March 2019. Study quality was assessed using the Delphi checklist. Due to the heterogeneity of the findings, a meta-analysis was not possible. Drug interventions for the treatment of sleep disorders in patients with ASD included melatonin, atomoxetine, and risperidone. Atomoxetine had no effect on sleep disorders in patients with ASD. A total of 10 studies were reviewed. Melatonin appears to be useful for the treatment of sleep problems in patients with ASD, but further studies are needed to determine the effects of other drugs.